ProShare Advisors’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-10,792
Closed -$371K 2000
2014
Q4
$371K Sell
10,792
-35,116
-76% -$1.15M ﹤0.01% 1367
2014
Q3
$1.37M Sell
45,908
-9,098
-17% -$193K 0.02% 932
2014
Q2
$1.1M Sell
55,006
-32,990
-37% -$757K 0.01% 1117
2014
Q1
$2.39M Buy
87,996
+62,564
+246% +$1.66M 0.03% 644
2013
Q4
$527K Sell
25,432
-23,058
-48% -$435K 0.01% 1065
2013
Q3
$884K Buy
48,490
+7,598
+19% +$137K 0.02% 966
2013
Q2
$680K Buy
+40,892
New +$653K 0.01% 1094

Other funds holding AUXL

ProShare Advisors's AUXL Position: Q1 2015 in Review

ProShare Advisors sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 10,792 shares — an estimated $371K sold.

ProShare Advisors first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $2.39M in Q1 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • ProShare Advisors reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • ProShare Advisors sold 10,792 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $371K.
  • ProShare Advisors first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • ProShare Advisors's AUXILIUM PHARAMCEUTICALS INC position peaked at $2.39M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on ProShare Advisors's 13F filing for Q1 2015, filed 8 May 2015.